Early, intracoronary growth hormone administration attenuates ventricular remodeling in a porcine model of myocardial infarction
Φόρτωση...
Ημερομηνία
Συγγραφείς
Mitsi, A. C.
Hatzistergos, K. E.
Niokou, D.
Pappa, L.
Baltogiannis, G. G.
Tsalikakis, D. G.
Papalois, A.
Kyriakides, Z. S.
Malamou-Mitsi, V.
Kolettis, T. M.
Τίτλος Εφημερίδας
Περιοδικό ISSN
Τίτλος τόμου
Εκδότης
Περίληψη
Τύπος
Είδος δημοσίευσης σε συνέδριο
Είδος περιοδικού
peer-reviewed
Είδος εκπαιδευτικού υλικού
Όνομα συνεδρίου
Όνομα περιοδικού
Growth Horm IGF Res
Όνομα βιβλίου
Σειρά βιβλίου
Έκδοση βιβλίου
Συμπληρωματικός/δευτερεύων τίτλος
Περιγραφή
OBJECTIVE: Ventricular remodeling is a common corollary of myocardial infarction. We hypothesized that this process may be attenuated by growth hormone, administered as a single high-dose, selectively in the infarct zone, early postmyocardial infarction. DESIGN: In 35 pigs (29+/-4 kg), myocardial infarction was generated by inflation of an over-the-wire angioplasty balloon in the circumflex artery for 60 min and 5 further pigs were sham-operated. Ten minutes after reperfusion, the pigs were randomized (2:1) to either growth hormone (1 IU/kg) (n=23) or normal saline (n=12), delivered via the balloon catheter. All survivors were treated with captopril and were sacrificed 4 weeks after myocardial infarction. RESULTS: Compared to controls, growth hormone-treated animals displayed lower heart weight (4.1+/-0.5 g/kg body weight, versus 3.4+/-0.4 g/kg, respectively, p=0.003) and dimensions (left ventricular short axis diameter 46+/-7 mm versus 37+/-6 mm, p=0.01; right ventricular short axis diameter 38+/-7 mm versus 30+/-5 mm p=0.001). Growth hormone increased wall thickness in the infarct (6.0+/-1.8 in controls versus 9.9+/-3.7 in treated animals, p=0.004) and non-infarct zones (10.6+/-1.8 in controls versus 15.5+/-3.8 in treated animals, p=0.0006) and produced higher (p<0.05) microvascular density in both zones. CONCLUSION: Intracoronary administration of growth hormone attenuates left and right ventricular remodeling by inducing hypertrophy and by enhancing angiogenesis.
Περιγραφή
Λέξεις-κλειδιά
Animals, Antihypertensive Agents/administration & dosage, Captopril/administration & dosage, Disease Models, Animal, Growth Hormone/*administration & dosage/*metabolism, Humans, Myocardial Infarction/*metabolism/pathology, Neovascularization, Pathologic/*chemically induced/metabolism/pathology, Swine, Ventricular Remodeling/*drug effects
Θεματική κατηγορία
Παραπομπή
Σύνδεσμος
http://www.ncbi.nlm.nih.gov/pubmed/16624608
http://ac.els-cdn.com/S1096637406000220/1-s2.0-S1096637406000220-main.pdf?_tid=34e29a5e2e9d33dfe71d8a7f25b84a5a&acdnat=1333700099_2ba55f39377fc1c9d8c4b055ca97ea1a
http://ac.els-cdn.com/S1096637406000220/1-s2.0-S1096637406000220-main.pdf?_tid=34e29a5e2e9d33dfe71d8a7f25b84a5a&acdnat=1333700099_2ba55f39377fc1c9d8c4b055ca97ea1a
Γλώσσα
en
Εκδίδον τμήμα/τομέας
Όνομα επιβλέποντος
Εξεταστική επιτροπή
Γενική Περιγραφή / Σχόλια
Ίδρυμα και Σχολή/Τμήμα του υποβάλλοντος
Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής